Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO
|
3 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.700 | 0 | ||||||||
INSULIN RESISTANCE, SUSCEPTIBILITY TO
|
3 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.700 | 0 | ||||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.100 | 0.841 | 44 | 1994 | 2019 | |||||
Polycystic Ovary Syndrome
|
363 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.100 | 0.833 | 18 | 2001 | 2017 | |||||
Gestational Diabetes
|
224 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.080 | 1.000 | 8 | 2005 | 2016 | |||||
Diabetes
|
710 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.050 | 1.000 | 5 | 1999 | 2014 | |||||
Diabetes Mellitus
|
824 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.050 | 1.000 | 5 | 1999 | 2014 | |||||
Obesity
|
1111 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.050 | 1.000 | 5 | 2001 | 2016 | |||||
Breast Carcinoma
|
2793 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2007 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2003 | 2004 | |||||
Malignant neoplasm of breast
|
3417 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2007 | 2018 | |||||
Malignant neoplasm of prostate
|
1082 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2005 | 2011 | |||||
Metabolic Syndrome X
|
591 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2009 | 2011 | |||||
Prostate carcinoma
|
1168 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.030 | 1.000 | 3 | 2005 | 2011 | |||||
Hypertensive disease
|
1085 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.020 | 1.000 | 2 | 2005 | 2011 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.020 | 1.000 | 2 | 2014 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.020 | 1.000 | 2 | 2005 | 2013 | |||||
Primary malignant neoplasm
|
1374 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.020 | 1.000 | 2 | 2005 | 2013 | |||||
Sleep Apnea, Obstructive
|
105 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
21-hydroxylase deficiency
|
28 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Carcinogenesis
|
355 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Carcinoma
|
103 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Colon Carcinoma
|
275 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
|
62 | 0.637 | 0.560 | 2 | 226795828 | missense variant | C/G;T | snv | 4.0E-06; 5.2E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 |